In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
After finishing at $4.45 in the prior trading day, Myriad Genetics, Inc (NASDAQ: MYGN) closed at $4.59, up 3.15%. In other words, the price has increased by $3.15 from its previous closing price. On the day, 1.22 million shares were traded. MYGN stock price reached its highest trading level at $4.65 during the session, while it also had its lowest trading level at $4.47.
Ratios:
Our goal is to gain a better understanding of MYGN by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.71 and its Current Ratio is at 1.90. In the meantime, Its Debt-to-Equity ratio is 0.22 whereas as Long-Term Debt/Eq ratio is at 0.21.
Wells Fargo Downgraded its Overweight to Equal Weight on May 07, 2025, while the target price for the stock was maintained at $6.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Oct 11 ’24 when DIAZ PAUL J sold 15,000 shares for $22.93 per share. The transaction valued at 343,950 led to the insider holds 962,378 shares of the business.
DIAZ PAUL J bought 15,000 shares of MYGN for $343,950 on Oct 11 ’24. On Aug 21 ’24, another insider, Ancona Margaret, who serves as the Officer of the company, bought 11,538 shares for $27.82 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MYGN now has a Market Capitalization of 423094272 and an Enterprise Value of 475989344. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.51 while its Price-to-Book (P/B) ratio in mrq is 0.60. Its current Enterprise Value per Revenue stands at 0.573 whereas that against EBITDA is -16.301.
Stock Price History:
The Beta on a monthly basis for MYGN is 1.91, which has changed by -0.83618844 over the last 52 weeks, in comparison to a change of 0.16260707 over the same period for the S&P500. Over the past 52 weeks, MYGN has reached a high of $29.30, while it has fallen to a 52-week low of $3.81. The 50-Day Moving Average of the stock is -4.77%, while the 200-Day Moving Average is calculated to be -60.40%.
Shares Statistics:
The stock has traded on average 2.30M shares per day over the past 3-months and 1320780 shares per day over the last 10 days, according to various share statistics. A total of 92.20M shares are outstanding, with a floating share count of 87.40M. Insiders hold about 5.19% of the company’s shares, while institutions hold 102.97% stake in the company. Shares short for MYGN as of 1751241600 were 7482557 with a Short Ratio of 3.25, compared to 1748563200 on 8776722. Therefore, it implies a Short% of Shares Outstanding of 7482557 and a Short% of Float of 11.459999999999999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
